William Blair & Company
PALI icon

William Blair & Company’s Palisade Bio PALI Stock Holding History

William Blair & Company’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1
Closed -$39K – 1757
2019
Q1 		$39K Hold
1
– – ﹤0.01% 1500
2018
Q4 		$27K Hold
1
– – ﹤0.01% 1457
2018
Q3 		$93K Hold
1
– – ﹤0.01% 1388
2018
Q2 		$97K Hold
1
– – ﹤0.01% 1345
2018
Q1 		$144K Hold
1
– – ﹤0.01% 1234
2017
Q4 		$150K Buy
+1
New +$130K ﹤0.01% 1293
2017
Q3 		– Sell
-1
Closed -$506K – 1469
2017
Q2 		$506K Buy
+1
New +$439K ﹤0.01% 979
2017
Q1 		– Hold
0
– – – 1262
2016
Q4 		– Hold
0
– – – 1206
2016
Q3 		– Hold
0
– – – 1213
2016
Q2 		– Hold
0
– – – 1159

Other funds holding PALI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

William Blair & Company's PALI Position: Q2 2019 in Review

William Blair & Company sold out of Palisade Bio (PALI) in Q2 2019, closing a stake of 1 share — an estimated $39K sold.

William Blair & Company first reported a position in PALI in Q2 2017 and held it in 7 quarters. The position peaked at $506K in Q2 2017. 6 funds tracked by Wall St. Rank hold PALI as of Q2 2019.

  • William Blair & Company reported no remaining Palisade Bio position as of Q2 2019 after selling out during the quarter.
  • William Blair & Company sold 1 Palisade Bio share in Q2 2019, an estimated $39K.
  • William Blair & Company first reported a position in Palisade Bio in Q2 2017 and held it in 7 quarters.
  • William Blair & Company's Palisade Bio position peaked at $506K in Q2 2017.
  • 6 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2019.

Based on William Blair & Company's 13F filing for Q2 2019, filed 13 Aug 2019.